Your browser doesn't support javascript.
loading
Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial.
Huang, Jian-Feng; Zhang, Fu-Zheng; Zou, Qin-Zhou; Zhou, Le-Yuan; Yang, Bo; Chu, Jian-Jun; Yu, Jia-Hua; Zhang, Hao-Wen; Yuan, Xiao-Peng; Tai, Guo-Mei; Liu, Fen-Ju; Ma, C-M Charlie.
Afiliação
  • Huang JF; Department of Radiobiology, School of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions and School for Rad
  • Zhang FZ; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Zou QZ; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Zhou LY; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Yang B; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Chu JJ; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Yu JH; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Zhang HW; Department of Radiobiology, School of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions and School for Rad
  • Yuan XP; Department of Radiobiology, School of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions and School for Rad
  • Tai GM; Department of Radiation Oncology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, China.
  • Liu FJ; Department of Radiation Oncology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, China.
  • Ma CC; Department of Radiobiology, School of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Medical College of Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions and School for Rad
Oncotarget ; 8(2): 2457-2465, 2017 Jan 10.
Article em En | MEDLINE | ID: mdl-27974693
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Nasofaríngeas / Anticorpos Monoclonais Humanizados / Quimiorradioterapia / Quimioterapia de Indução / Antineoplásicos Imunológicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Nasofaríngeas / Anticorpos Monoclonais Humanizados / Quimiorradioterapia / Quimioterapia de Indução / Antineoplásicos Imunológicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article